Sars-CoV2

Showing 51 - 75 of 123

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Intensive Care Associated Complications and Outcome of Acute

Recruiting
  • COVID
  • +2 more
  • Study Arm
  • Bern, Switzerland
    Inselspital Bern
Jul 8, 2021

Immune Response Against COVID-19 Among Hospital Staff

Active, not recruiting
  • Sars-CoV2
  • Clinical interview
  • +2 more
  • Clamart, France
    Hôpital d'Instuction des Armées Percy
Jul 6, 2021

COVID, Sars-CoV2, ARDS, Human Trial (Tadalafil Pill)

Withdrawn
  • COVID
  • +2 more
  • Tadalafil Pill
  • (no location specified)
Jun 30, 2021

Sars-CoV2 Trial in La Mesa, San Diego (Octagam)

Completed
  • Sars-CoV2
  • La Mesa, California
  • +1 more
Jun 23, 2021

COVID, ARDS, Human, Ards Trial in Milano (IC14, a mAb against CD14)

No longer available
  • COVID
  • +3 more
  • IC14, a monoclonal antibody against CD14
  • Milano, Italy
    IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffael
Jun 15, 2021

COVID-19 on Pediatric Dental Practice During First, Second And

Recruiting
  • SARS-CoV2
    • Cairo, Egypt
      Faculty of Oral and Dental Medicine, Cairo University
    Jun 11, 2021

    Sars-CoV2, Covid-19, Pregnancy Complications Trial in Sweden (biological samples, questionnaires and interviews)

    Recruiting
    • Sars-CoV2
    • +5 more
    • biological samples, questionnaires and interviews
    • Falun, Dalarna, Sweden
    • +26 more
    Jun 3, 2021

    COVID 19, Coronavirus, Diabetes, Type 2 Trial in Be'er Ya'aqov, Petah tikva (Linagliptin 5 MG)

    Terminated
    • COVID 19
    • +14 more
    • Linagliptin 5 MG
    • Be'er Ya'aqov, Israel
    • +2 more
    May 28, 2021

    Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS), Respiratory Failure, Sars-CoV2 Trial in San Antonio (Rapamycin,

    Withdrawn
    • Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS)
    • +2 more
    • San Antonio, Texas
    • +1 more
    May 27, 2021

    Clinical Features of Severe Patients With COVID-19

    Completed
    • SARS-CoV2
    • The demographic, clinical, laboratory, and instrumental data
    • Moscow, Russian Federation
      Federal Research Clinical Center of Federal Medical & Biological
    May 19, 2021

    Post-traumatic Stress of Patients Hospitalized in Intensive Care

    Active, not recruiting
    • Intensive Care Unit
    • SARS-CoV2
      • Paris, Ile De France, France
        GH Pitié Salpêtrière - Charles Foix
      May 14, 2021

      COVID-19, Sars-CoV2, Cancer Trial in Augusta, Columbus (TL-895)

      Completed
      • COVID-19
      • +5 more
      • Augusta, Georgia
      • +1 more
      May 10, 2021

      COVID, Severe Acute Respiratory Syndrome, Sars-CoV2 Trial in Canada, Turkey, United States (LSALT peptide, Placebo)

      Active, not recruiting
      • COVID
      • +3 more
      • LSALT peptide
      • Placebo
      • San Diego, California
      • +6 more
      May 5, 2021

      Respiratory Distress Syndrome, Adult, Sars-CoV2 Trial in Baltimore (Hypothermia, Neuromuscular Blocking Agents, Standard of

      Withdrawn
      • Respiratory Distress Syndrome, Adult
      • Sars-CoV2
      • Hypothermia
      • +2 more
      • Baltimore, Maryland
        University of Maryland Medical Center
      Apr 27, 2021

      Echocardiography in Critically-ill COVID-19 Pneumonia

      Enrolling by invitation
      • COVID
      • Sars-CoV2
        • Boulogne-Billancourt, Hauts De Seine, France
          University Hospital Ambroise Pare
        Apr 28, 2021

        Severe Acute Respiratory Syndrome Coronavirus 2, SARS-CoV2 Trial in Sao Paulo (Janus Kinase Inhibitor (ruxolitinib), Placebo)

        Terminated
        • Severe Acute Respiratory Syndrome Coronavirus 2
        • SARS-CoV2
        • Janus Kinase Inhibitor (ruxolitinib)
        • Placebo
        • Sao Paulo, Brazil
          Hospital das Clínicas
        Apr 5, 2021

        COVID, Covid-19, Corona Virus Infection Trial in Ventura (ResCure™)

        Withdrawn
        • COVID
        • +6 more
        • ResCure™
        • Ventura, California
          ProgenaBiome
        Apr 6, 2021

        SARS-CoV2, COVID-19 Trial in Ankara, Istanbul (Ribavirin Capsules, Favipiravir)

        Not yet recruiting
        • SARS-CoV2
        • COVID-19
        • Ankara, Cebeci, Turkey
        • +3 more
        Apr 1, 2021

        Immune Cells Phenotypes During COVID-19

        Recruiting
        • Sars-CoV2
        • +4 more
        • Peripheral blood samples
        • Marseille, France
        • +1 more
        Mar 24, 2021

        Thrombomodulin-modified Thrombin Generation Assay in Critical

        Completed
        • Disseminated Intravascular Coagulation
        • +5 more
        • Thrombin Generation Assay (TGA)
        • Thrombomodulin Modified Thrombin Generation Assay (TGA-TM)
        • Vienna, Austria
          Medical University Vienna
        Mar 22, 2021

        Sars-CoV2 Trial in Timisoara, Reus, Tarragona (Recombinant human plasma gelsolin (Rhu-pGSN), Placebo)

        Active, not recruiting
        • Sars-CoV2
        • Recombinant human plasma gelsolin (Rhu-pGSN)
        • Placebo
        • Timişoara, Romania
        • +2 more
        Mar 12, 2021

        Covid-19, Sars-CoV2, Pneumonia Trial in Colombia, United States (Low dose radiation 35 cGy, High dose radiation 100 cGy)

        Recruiting
        • Covid-19
        • +2 more
        • Low dose radiation 35 cGy
        • High dose radiation 100 cGy
        • Boca Raton, Florida
        • +7 more
        Mar 11, 2021

        Sars-CoV2, Symptomatic Condition, Covid-19 Trial in Lahore (Hydroxychloroquine Sulfate Regular dose, Hydroxychloroquine Sulfate

        Terminated
        • Sars-CoV2
        • +2 more
        • Hydroxychloroquine Sulfate Regular dose
        • +3 more
        • Lahore, Punjab, Pakistan
        • +3 more
        Mar 8, 2021

        SARS-COV-2 Serological Profile ofArmy Training Hospital Staff

        Completed
        • Sars-CoV2
        • Anti-SARS-CoV2 Serology
        • Questionnaire
        • Toulon, France
        • +1 more
        Mar 8, 2021